logo
Select company
Select metric
$ -45.81MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
14
Sector
35
Industry
49
History
39
$ 173.6Close
$ 4.5 - $ 182.6 52-Week Range
Ticker Information

Ticker

SPRB

Company Name

SPRUCE BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SPRUCE BIOSCIENCES INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SPRB - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 289K$ -46.1M$ -45.81M
3/31/2025$ 289K$ -54.1M$ -53.81M
12/31/2024$ 293K$ -52.73M$ -52.44M
9/30/2024$ 295K$ -41.92M$ -41.63M
6/30/2024$ 297K$ -44.75M$ -44.45M
3/31/2024$ 298K$ -47.41M$ -47.11M
12/31/2023$ 300K$ -47.44M$ -47.14M
9/30/2023$ 354K$ -48.61M$ -48.25M
6/30/2023$ 387K$ -47.66M$ -47.28M
3/31/2023$ 403K$ -46.74M$ -46.34M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SPRUCE BIOSCIENCES INC's latest trailing twelve months (TTM) EBITDA stands at $ -29.11M.
  • Over the past 5 years, SPRUCE BIOSCIENCES INC's average EBITDA has been $ -44.47M.
  • The median EBITDA for SPRUCE BIOSCIENCES INC during this period was $ -44.89M
  • SPRUCE BIOSCIENCES INC reached its highest EBITDA over the past 5 years at $ -29.11M.
  • The lowest EBITDA recorded by SPRUCE BIOSCIENCES INC in the same timeframe $ -53.81M

SPRUCE BIOSCIENCES INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
ONCO : ONCONETIX INC $ -43.75MSXTP : 60 DEGREES PHARMACEUTICALS INC $ -7.74MVIVS : VIVOSIM LABS INC $ -1.17MXBIO : XENETIC BIOSCIENCES INC $ -3.08MOGEN : ORAGENICS INC $ -9.51MADTX : ADITXT INC $ -29.78MCDT : CONDUIT PHARMACEUTICALS INC $ -16.52MGTBP : GT BIOPHARMA INC $ -9.39MKTTA : PASITHEA THERAPEUTICS CORP $ -12.81MTCRT : ALAUNOS THERAPEUTICS INC $ -3.99M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for SPRUCE BIOSCIENCES INC is calculated as follows: EBIT [ $ -29.22M ] + DepAmor [ $ 102K ]
(=) EBITDA [ $ -29.11M ]

SPRB - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -53.81M

Minimum

Mar 31, 2025

$ -29.11M

Maximum

Dec 31, 2020

$ -44.47M

Average

$ -44.89M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M